TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
Sports
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | United StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
News Columns | Kashmir AngleJammu JournalInside the CapitalHimachal CallingHill View
Don't Miss
Advertisement

Govt allows Ramdev to market Patanjali's Coronil as immunity booster; not authorised for Covid therapy

Patanjali Trust had initiated clinical trials for COVID-19 therapy

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

Aditi Tandon
Tribune News Service
New Delhi, July 1

Advertisement

After banning the advertisement for Patanjali Trust’s new drug, Coronil for “COVID-19 treatment”, the government on Wednesday said, the firm could market the medicine as an immunity booster, and not as a COVID-19 drug.

Advertisement

In a letter to Uttarakhand Licensing Authority and Ramdev’s Patanjali Trust, the Ministry of Ayush said that it examined the matter and found that Coronil was registered with a state licensing authority as an immunity booster. The two other drugs, in the so-called COVID-19 package, which Patanjali announced was registered as Ayurvedic drugs for ‘Kasa and Savasa’.

Earlier this June, the Trust had applied for the licences with the state authority.

The Ministry letter to Ramdev reads: “The proposed three drugs—Divya Coronil tablet, Divya Shwashari Vati 540MG and Divya Shwashari Vati 350 MG should be marketed as per the scope of the licence issued by Uttarakhand Licensing Authority, Ayurvedic and Unani Services. On the package and label of these drugs no claim of cure of COVID-19 should be mentioned.”

Advertisement

The Ministry added that Patanjali Trust had initiated clinical trials for COVID-19 therapy, as per the government guideline, and the Trust could continue those trials as per the required procedure.

Advertisement
Show comments
Advertisement